<DOC>
	<DOCNO>NCT02270892</DOCNO>
	<brief_summary>Up 24 subject enrol treat . Enrolled subject receive two Ulthera® treatment , 90 day apart . Follow-up visit occur 90 , 180 , 270 day follow last treatment . Study image obtain pre-treatment , immediately post-treatment , follow-up visit .</brief_summary>
	<brief_title>Ultherapy Buttock Lift</brief_title>
	<detailed_description>This study prospective , single-blinded , randomize , split-body clinical study conduct one clinical site . Investigator assess baseline buttock ptosis confirm subject eligibility . Enrolled subject meet entrance criterion confirm eligible study treatment randomized/assigned one two treatment group : `` Right side treat '' `` Left side treat '' . All subject receive two , single-sided , dual-depth Ultherapy® treatment use 4-4.5mm 7-3.0mm transducer 0.90J 0.30J , respectively . Standardized image take use standard 2D Vectra 3D digital image system . Subjects complete study visit give option receive two balance treatment , 90 day apart , require complete one study visit 90 day follow last balancing treatment . Quantititative qualititative assessment pre- versus post-treatment buttock ptosis complete post-treatment time point . Subjects also complete questionnaire study visit .</detailed_description>
	<criteria>1 . Female , age 18 65 year . 2 . Subject good health . 3 . Mild moderate buttock ptosis base Investigator evaluation . 4 . BMI &lt; 25 . 5 . No history weight gain loss great 10 pound within past year . 6 . No planned weight loss gain duration study . 7 . No pregnancy within past year . 8 . Willingness refrain use aspirin , Ibuprofen , Naproxen NSAID prior study treatment chronic use entire posttreatment study period . If chronic user , washout period 4 week require prior study treatment # 1 . Washout period limit acute NSAID use , i.e. , maximum 23 dos , require 2 week prior study treatment visit . 9 . No immunosuppressive therapy , e.g. , oral steroid treatment , within past 4 week entire posttreatment study period . Washout period , recent use , 4 week prior study treatment # 1 . 10 . Subject must desire improvement buttock ptosis demonstrate Dissatisfaction response baseline Patient Satisfaction Questionnaire , i.e. , Dissatisfied , Neither Satisfied Dissatisfied , Slightly Satisfied , Satisfied , Very Satisfied . 11 . Willingness refrain receive spray tan use selftanning lotion midthigh waist within 2 week study assessment duration trial . 12 . Willingness avoid much possible , direct prolong sun exposure midthigh waist duration study . 13 . Willingness refrain topical steroid use , tretinoin , caffeine cream prescription overthecounter cellulite reduction topicals affect area 2 week prior study treatment # 1 duration study period . 14 . Understands accepts obligation undergo procedure area treat followup period . 15 . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . 16 . Subjects childbearing potential must negative urine pregnancy test result must lactate Baseline Visit willing able use acceptable method birth control ( e.g . barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow condition document medical history : 1 . Postmenopausal least 12 month prior study ; 2 . Without uterus and/or ovary ; 3 . Bilateral tubal ligation least six month prior study enrollment . 17 . Absence physical psychological condition unacceptable investigator . 18 . Willingness ability provide write consent studyrequired photography adherence photography procedure . 19 . Willingness ability provide write informed consent HIPAA authorization prior performance studyrelated procedure . 1 . Radiofrequency , CoolSculpting , liposuction , energybased treatment area treat body contouring , fat reduction , improvement cellulite , reduction buttock ptosis within 1 year prior study participation study . 2 . Shortwave massage therapy area treat treatment cellulite buttock ptosis within 3 month prior study participation study . 3 . BMI great equal 25 . 4 . Presence active systemic local skin disease may affect wound healing . 5 . Excessive subcutaneous fat area treat . 6 . Excessive skin laxity area treat . 7 . Severe buttock ptosis . 8 . Significant scar tattoos area treat would interfere assess result . 9 . Open wound lesion area treat . 10 . Inability understand protocol give inform consent . 11 . History chronic drug alcohol abuse . 12 . History autoimmune disease . 13 . Has know allergy know contraindication ketorolac tromethamine ( Toradol ) . 14 . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study device . 15 . Subjects anticipate need inpatient surgery overnight hospitalization study . 16 . Subjects , investigator 's opinion , history poor cooperation , noncompliance medical treatment , unreliability . 17 . Concurrent enrollment study involve use investigational device drug . 18 . Current smoker history smoking last 5 year . 19 . Current user nicotinecontaining product , e.g. , ecigarettes , Nicorette gum , nicotine patch , etc . 20 . History follow cosmetic treatment area treat : 1 . Skin tighten procedure within past year ; 2 . Buttock implant ; 3 . Buttock filler ( e.g. , silicone , semipermanent permanent filler autologous fat injection ) ; 4 . Fat emulsifier ; 5 . Injections treatment cellulite . 21 . History use follow prescription medication : 1 . Accutane systemic retinoids within past 6 month ; 2 . Topical retinoids , tretinoin , caffeine cream prescription overthecounter cellulite reduction topicals within past 2 week ; 3 . Antiplatelet agents/Anticoagulants ( Coumadin , Heparin , Plavix ) ; 4 . Psychiatric drug investigator opinion would impair subject understand protocol requirement understand signing informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ulthera , Ulthera System , Ultherapy</keyword>
</DOC>